Article

Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion?

2023-11-07

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Drug formularies, initially designed to promote the use of cost-effective generic drugs are now designed to maximize financial benefits for the pharmacy benefit management companies that negotiate drug purchase prices. In the largest publicly available formulary, 55% of mandated substitutions are not for generic versions of the same active ingredient and/or formulation and may...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 224141c3-d510-5143-ab0b-ba8007634caa
DOI: 10.1101/2023.10.31.23297782

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion?DOI 10.1101/2023.10.31.23297782Read

Lomitapide: A Medication Use Evaluation & a Formulary PerspectiveSemantic proximity Read

Management of possible drug-drug interactions in medical prescriptions received in pharmaciesSemantic proximity Read

Factors Associated with Drug Interactions in Medical Prescriptions Received in Community Pharmacies in YaoundéSemantic proximity Read

Treatment discontinuation in atypical hemolytic uremic syndrome (aHUS): A qualitative study of international experts’ perspectives with associated cost-consequence analysisSemantic proximity Read

Intentional and unintentional non-adherence in hypertension: psychometric validation, adherence-complexity phenotyping and causal mediation analysis from the VATAHTA Study.Semantic proximity Read

Cost avoidance of pharmacist-led deprescribing using STOPPFrail for older adults in nursing homesSemantic proximity Read

Pharmacovigilance analysis of inclisiran:a real-world assessment based on the FAERS databaseSemantic proximity Read

Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): Protocol for a primary care based, open-label, randomised controlled non-inferiority trialSemantic proximity Read

The public health impact of suspending cyproterone acetate/ ethinylestradiol (Diane-35 and generics) in France: A predictive modelling techniqueSemantic proximity Read

An international study to investigate and optimise the safety of discontinuing valproate in young men and women with epilepsy: protocolSemantic proximity Read

Tools and guidelines to assess the appropriateness of medication and aid the deprescribing: an umbrella reviewSemantic proximity Read

Use of over-the-counter-like drugs among adults with indicated chronic diseases: A nationwide descriptive study in JapanSemantic proximity Read